No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DOCS240719C27500
- 1.80
- +0.70+63.64%
15min DelayClose Jul 16 16:00 ET
1.80High1.20Low
1.40Open1.10Pre Close25 Volume638 Open Interest27.50Strike Price4.15KTurnover121.94%IV-0.17%PremiumJul 19, 2024Expiry Date1.85Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.7452Delta0.1010Gamma12.36Leverage Ratio-0.1909Theta0.0015Rho9.21Eff Leverage0.0084Vega
Intraday
- 5D
- Daily
News
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $29
Evercore analyst Elizabeth Anderson CFA maintains $Doximity(DOCS.US)$ with a hold rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate of 37.7%
We Like These Underlying Return On Capital Trends At Doximity (NYSE:DOCS)
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in c
Doximity(DOCS.US) Director Sells US$70,000 in Common Stock
$Doximity(DOCS.US)$ Director Wampler Kira Scherer sold 2,500 shares of common stock on Jul 1, 2024 at an average price of $28 for a total value of $70,000.Source: Announcement What is statement of cha
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note
Morgan Stanley Maintains Doximity(DOCS.US) With Sell Rating, Maintains Target Price $25
Morgan Stanley analyst Craig Hettenbach maintains $Doximity(DOCS.US)$ with a sell rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 0.0% and a
Should You Think About Buying Doximity, Inc. (NYSE:DOCS) Now?
Comments
$Doximity(DOCS.US$
from the list. so far its hold that daily support 27.61/27.93 we could see a retest of that montly 28.82/29.26 and maybe 30.40/30.74. if DOCS breaks below, it could test 26.97 or lower 25.98/26.69.
from the list. so far its hold that daily support 27.61/27.93 we could see a retest of that montly 28.82/29.26 and maybe 30.40/30.74. if DOCS breaks below, it could test 26.97 or lower 25.98/26.69.
2
Doximity's high P/E ratio is backed by its promising earnings outlook. Shareholders, confident in future earnings, are holding onto their shares. The company's robust earnings growth and positive future outlook bolster its share price.
2
The telehealth market shone brightly, valued at $128.12 billion. The market is poised for a stellar ascent, forecasted to skyrocket from $142.96 billion in 2023 to a staggering $504.24 billion by 2030. This growth, marked by a robust 19.7% CAGR, highlights the sector’s burgeoning potential, as noted by Fortune Business Insights. The growth of telehealth is significant. It underscores its transformative impact on the future landscape of healthcare.
![]()
$Teladoc Health(TDOC.US$
A...
A...
+2
7
Analysts from William Blair and Raymond James rate DOCS shares as 'Outperform', remaining optimistic about the company's future. They find the solid results and improved guidance range to be a positive step.
Doximity's underpriced shares and forecasted profitability increase its appeal among big growth investors. Its bright future prospects are not entirely factored into its current share price. However, it's recommended to examine the company's finance before investment.
Read more